Global Medical REIT Inc. (GMRE) To Go Ex-Dividend on December 19th

Global Medical REIT Inc. (NYSE:GMREGet Free Report) declared a quarterly dividend on Thursday, December 4th. Investors of record on Friday, December 19th will be given a dividend of 0.75 per share on Friday, January 9th. This represents a c) annualized dividend and a yield of 8.5%. The ex-dividend date of this dividend is Friday, December 19th.

Global Medical REIT has increased its dividend by an average of 0.0%per year over the last three years. Global Medical REIT has a payout ratio of 6,000.0% meaning the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities research analysts expect Global Medical REIT to earn $0.84 per share next year, which means the company may not be able to cover its $3.00 annual dividend with an expected future payout ratio of 357.1%.

Global Medical REIT Stock Up 0.5%

Shares of NYSE GMRE opened at $35.43 on Wednesday. The company has a debt-to-equity ratio of 1.65, a current ratio of 0.52 and a quick ratio of 0.52. The stock has a market capitalization of $475.12 million, a PE ratio of -141.72 and a beta of 1.17. Global Medical REIT has a one year low of $29.05 and a one year high of $45.75. The business’s fifty day moving average price is $32.37 and its 200-day moving average price is $33.84.

Global Medical REIT (NYSE:GMREGet Free Report) last posted its earnings results on Tuesday, November 4th. The company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.07. Global Medical REIT had a net margin of 0.79% and a return on equity of 0.25%. The firm had revenue of $37.23 million during the quarter, compared to the consensus estimate of $38.15 million. Global Medical REIT has set its FY 2025 guidance at 4.500-4.600 EPS. On average, equities research analysts anticipate that Global Medical REIT will post 0.81 EPS for the current year.

Analysts Set New Price Targets

GMRE has been the subject of a number of analyst reports. Citigroup raised Global Medical REIT to an “outperform” rating in a report on Monday, October 13th. Zacks Research upgraded Global Medical REIT from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, September 24th. Wall Street Zen lowered Global Medical REIT from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. JMP Securities set a $40.00 price target on shares of Global Medical REIT and gave the stock a “market outperform” rating in a report on Monday, October 13th. Finally, Weiss Ratings lowered shares of Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Global Medical REIT currently has an average rating of “Moderate Buy” and a consensus price target of $41.50.

View Our Latest Stock Analysis on Global Medical REIT

About Global Medical REIT

(Get Free Report)

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

See Also

Dividend History for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.